Quantitative Systems Pharmacology: A Case for Disease Models

被引：48
|
作者：
Musante, C. J. [1 ]
Ramanujan, S. [2 ]
Schmidt, B. J. [3 ]
Ghobrial, O. G.
Lu, J. [4 ]
Heatherington, A. C. [1 ]
机构：
[1] Pfizer Inc, Cambridge, MA 02139 USA
[2] Genentech Inc, San Francisco, CA USA
[3] Bristol Myers Squibb, Princeton, NJ USA
[4] AstraZeneca, Cambridge, England
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / 01期
关键词：
PHARMACEUTICAL-INDUSTRY; MONOCLONAL-ANTIBODIES; DRUG DEVELOPMENT; THERAPEUTICS; CHALLENGES; INNOVATION; DISCOVERY;
D O I：
10.1002/cpt.528
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Quantitative systems pharmacology (QSP) has emerged as an innovative approach in model-informed drug discovery and development, supporting program decisions from exploratory research through late-stage clinical trials. In this commentary, we discuss the unique value of disease-scale "platform" QSP models that are amenable to reuse and repurposing to support diverse clinical decisions in ways distinct from other pharmacometrics strategies.
引用
收藏
页码：24 / 27
页数：4
相关论文
共 50 条
  • [1] Algorithms and methodological challenges in the development and application of quantitative systems pharmacology models: a case study in type 2 diabetes
    Sokolov, Victor
    RUSSIAN JOURNAL OF NUMERICAL ANALYSIS AND MATHEMATICAL MODELLING, 2022, 37 (05) : 293 - 309
  • [2] The promises of quantitative systems pharmacology modelling for drug development
    Knight-Schrijver, V. R.
    Chelliah, V.
    Cucurull-Sanchez, L.
    Le Novere, N.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2016, 14 : 363 - 370
  • [3] Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
    Neves-Zaph, Susana
    Kaddi, Chanchala
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (06) : 1442 - 1451
  • [4] Computational methods and applications for quantitative systems pharmacology
    Xie, Fuda
    Gu, Jiangyong
    QUANTITATIVE BIOLOGY, 2019, 7 (01) : 3 - 16
  • [5] Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists
    Ramasubbu, Mathan Kumar
    Paleja, Bhairav
    Srinivasann, Anand
    Maiti, Rituparna
    Kumar, Rukmini
    INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (04) : 268 - 276
  • [6] A quantitative systems pharmacology (QSP) model for Pneumocystis treatment in mice
    Liu, Guan-Sheng
    Ballweg, Richard
    Ashbaugh, Alan
    Zhang, Yin
    Facciolo, Joseph
    Cushion, Melanie T.
    Zhang, Tongli
    BMC SYSTEMS BIOLOGY, 2018, 12
  • [7] Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease
    Fang, Jiansong
    Cai, Chuipu
    Chai, Yanting
    Zhou, Jingwei
    Huang, Yujie
    Gao, Li
    Wang, Qi
    Cheng, Feixiong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 161 : 192 - 204
  • [8] Quantitative Disease, Drug, and Trial Models
    Gobburu, Jogarao V. S.
    Lesko, Lawrence J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 : 291 - 301
  • [9] Mechanisms of Action of Autophagy Modulators Dissected by Quantitative Systems Pharmacology Analysis
    Shi, Qingya
    Pei, Fen
    Silverman, Gary A.
    Pak, Stephen C.
    Perlmutter, David H.
    Liu, Bing
    Bahar, Ivet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [10] Target Site Delivery and Residence of Nanomedicines: Application of Quantitative Systems Pharmacology
    Au, Jessie L-S
    Abbiati, Roberto A.
    Wientjes, M. Guillaume
    Lu, Ze
    PHARMACOLOGICAL REVIEWS, 2019, 71 (02) : 157 - 169
12345